Rayaldee Alternatives Compared
Rayaldee (calcifediol) | Parsabiv (etelcalcetide) | Calcifediol |
|
---|
Rayaldee (calcifediol) | Parsabiv (etelcalcetide) | Calcifediol |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Hyperparathyroidism Secondary to Renal Impairment. Rayaldee may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperparathyroidism Secondary to Renal Impairment. Parsabiv may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperparathyroidism Secondary to Renal Impairment, Renal Osteodystrophy, Hypocalcemia. Calcifediol may also be used for purposes not listed in this medication guide. |
Related suggestions Hyperparathyroidism Secondary to Renal Impairment
|
|||||||||||||||
More about Rayaldee (calcifediol) | More about Parsabiv (etelcalcetide) | More about Calcifediol | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Rayaldee has an average rating of 7.5 out of 10 from a total of 6 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
Calcifediol has an average rating of 7.5 out of 10 from a total of 6 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Rayaldee prices |
View all Parsabiv prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
Rayaldee | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
528 hours |
96 hours |
528 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 90 drugs are known to interact with Rayaldee:
|
A total of 21 drugs are known to interact with Parsabiv:
|
A total of 90 drugs are known to interact with Calcifediol:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
June 17, 2016 |
February 07, 2017 |
June 17, 2016 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.